Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
ABOS compared with ARTV: revenue, margins and what each company keeps, and the suppliers and customers both name
ABOS
Acumen Pharmaceuticals, Inc.
Change
Mkt cap
Revenue
Revenue
ARTV
Artiva Biotherapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
ABOS
Acumen Pharmaceuticals, Inc.
vs
ARTV
Artiva Biotherapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
ABOS: latest quarter not drawable. ARTV: latest quarter is a loss; flow not drawable.
Method
›
ABOS
Acumen Pharmaceuticals, Inc.
Change
0.22
· pre 0.23
Mkt cap
$15.2M
Revenue
—
ARTV
Artiva Biotherapeutics, Inc.
Change
4.19
· pre 4.19
· delayed
Pre-market
Sep 2 '83
Mkt cap
$204.8M
Revenue
$251,000
Q1 FY24
vs
Compare
Pre-market
Sep 2 '83
ABOS
Acumen Pharmaceuticals, Inc.
vs
ARTV
Artiva Biotherapeutics, Inc.
0.22
pre 0.23
Price
4.19
pre 4.19
delayed
$15.2M
Mkt cap
$204.8M
—
Revenue
$251,000
Q1 FY24
Change
Change
ABOS
0.22
vs
ARTV
4.19
Pre-market
Sep 2 '83
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only ABOS
5
MRK
Merck
supplier
HALO
Halozyme
supplier
—
JCR Pharmaceuticals
unlisted
supplier
—
Lonza Sales
unlisted
supplier
1 more · ABOS chain
›
Shared
0
No shared counterparties.
Only ARTV
1
—
GC Cell
unlisted
supplier
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
ABOS, solid
ARTV, dashed